# Literature Review: Review on Nanoparticles and Nanostructured Materials- Bioimaging, Biosensing, Drug Delivery, Tissue Engineering, Antimicrobial, and Agro-Food Applications.

*Generated on: 2025-12-26 19:40:07*
*Progress: [20/50]*
*Saved to: /Users/joanna/Desktop/Literature_Reviews/Review_on_Nanoparticles_and_Nanostructured_Materials-_Bioima_20251226_194007.md*
---

# Review on Nanoparticles and Nanostructured Materials: Bioimaging, Biosensing, Drug Delivery, Tissue Engineering, Antimicrobial, and Agro-Food Applications

**Key Points**
*   **Versatility of Nanomaterials:** Nanomaterials (1–100 nm) exhibit unique physicochemical properties (high surface-to-volume ratio, quantum effects) that differ significantly from their bulk counterparts, enabling revolutionary applications across medicine and agriculture.
*   **Biomedical Dominance:** Lipid nanoparticles (LNPs) and liposomes represent the most clinically advanced nanomedicines (e.g., Doxil, Onpattro, COVID-19 vaccines), while gold nanoparticles and quantum dots are transforming bioimaging and biosensing through surface plasmon resonance and fluorescence.
*   **Agricultural & Food Innovation:** Nanotechnology is reshaping the agro-food sector through nano-fertilizers for targeted nutrient delivery, smart packaging with embedded nanosensors for spoilage detection, and antimicrobial coatings to extend shelf life.
*   **Critical Challenges:** Despite technical success, the field faces significant hurdles regarding long-term toxicity, environmental bioaccumulation, and regulatory divergence, exemplified by the European Food Safety Authority’s (EFSA) ban on Titanium Dioxide (E171) as a food additive due to genotoxicity concerns.

---

## Abstract

The rapid evolution of nanotechnology has catalyzed a paradigm shift in materials science, particularly within the biomedical and agro-food sectors. This systematic literature review provides a comprehensive analysis of nanoparticles (NPs) and nanostructured materials, focusing on their synthesis, characterization, and multifaceted applications. We examine the historical trajectory of the field, from ancient artisanal uses to modern microfluidic synthesis and green chemistry approaches. The review critically evaluates state-of-the-art applications in six key domains: bioimaging, biosensing, drug delivery, tissue engineering, antimicrobial therapies, and agro-food systems. Special attention is given to the mechanisms of action, such as reactive oxygen species (ROS) generation in antimicrobial applications and the enhanced permeability and retention (EPR) effect in oncology. Furthermore, we address the pressing challenges of nanotoxicology, regulatory discrepancies between global agencies (FDA vs. EFSA), and the environmental fate of engineered nanomaterials. The paper concludes by identifying research gaps and proposing future directions for the development of sustainable, biocompatible, and "smart" nanostructured systems.

---

## 1. Introduction

In the last few decades, the manipulation of matter at the atomic and molecular scale has transitioned from theoretical physics to a dominant force in global industry and healthcare. Nanotechnology, defined by the engineering of functional systems at the molecular scale, utilizes materials where at least one dimension falls within the 1 to 100 nanometer range [cite: 1, 2]. The motivation behind the extensive investigation of nanomaterials lies in their high surface-area-to-volume ratio and quantum confinement effects, which endow them with superior optical, electrical, magnetic, and catalytic properties compared to bulk materials [cite: 3, 4].

The objectives of this review are to synthesize recent literature regarding the synthesis and application of various nanomaterial types—including spherical nanoparticles, nanorods, nanotubes, and nanosheets—across diverse sectors. While the biomedical potential of nanoparticles for drug delivery and tissue engineering is well-documented, their convergence with agro-food applications represents a burgeoning frontier [cite: 1, 5]. This paper aims to provide a holistic view of how nanostructured materials are addressing critical global challenges, from multidrug-resistant bacteria and cancer therapy to food security and sustainable agriculture, while simultaneously critically analyzing the safety and regulatory hurdles that threaten to impede widespread adoption.

---

## 2. Key Concepts and Definitions

### 2.1. Defining the Nanoscale
Nanoparticles (NPs) are typically defined as particulate dispersions or solid particles with a size in the range of 10–100 nm [cite: 6]. However, in pharmaceutical and materials science contexts, the term often encompasses structures up to 500 nm or even 1000 nm, provided they exhibit size-dependent properties [cite: 6, 7].

### 2.2. Classification of Nanomaterials
Nanomaterials are generally classified based on their dimensions and composition:
*   **Dimensionality:**
    *   **0D:** All dimensions at the nanoscale (e.g., quantum dots, nanoclusters).
    *   **1D:** One dimension outside the nanoscale (e.g., nanotubes, nanowires, nanofibers) [cite: 6].
    *   **2D:** Two dimensions outside the nanoscale (e.g., nanosheets, graphene).
    *   **3D:** Bulk materials with nanoscale features (e.g., mesoporous materials, nanocomposites).
*   **Composition:**
    *   **Inorganic NPs:** Includes metals (Au, Ag), metal oxides (ZnO, TiO2, Fe3O4), and ceramics (hydroxyapatite, silica) [cite: 3, 8].
    *   **Organic NPs:** Includes polymeric nanoparticles, lipid-based systems (liposomes, solid lipid nanoparticles), and dendrimers [cite: 9, 10].
    *   **Carbon-based Nanomaterials:** Includes carbon nanotubes (CNTs), graphene, and fullerenes [cite: 11, 12].

---

## 3. Historical Development and Milestones

The history of nanotechnology predates its scientific definition. Ancient artisans unwittingly utilized nanotechnology to create dichroic glass and robust steel.

### 3.1. Ancient and Pre-Modern Era
*   **The Lycurgus Cup (4th Century AD):** A Roman glass chalice that appears green in reflected light and ruby red in transmitted light. Modern transmission electron microscopy (TEM) revealed this effect is due to embedded gold and silver nanoparticles (~50–70 nm) [cite: 13, 14].
*   **Damascus Steel (c. 900 AD):** Renowned for its strength and sharpness, recent analyses have discovered carbon nanotubes and cementite nanowires within the steel matrix [cite: 15, 16].
*   **Michael Faraday (1857):** In the first scientific study of nanomaterials, Faraday synthesized colloidal gold, observing that the color of the solution depended on the particle size, thereby establishing the connection between optical properties and physical dimensions [cite: 16, 17].

### 3.2. The Birth of Modern Nanotechnology
*   **Richard Feynman (1959):** In his seminal lecture "There's Plenty of Room at the Bottom," Feynman conceptualized the manipulation of individual atoms, laying the theoretical groundwork for the field [cite: 13, 17].
*   **Norio Taniguchi (1974):** Coined the term "nanotechnology" to describe precision engineering at the nanometer scale [cite: 16, 17].
*   **Scanning Tunneling Microscope (1981):** The invention of the STM by Binnig and Rohrer allowed scientists to image and manipulate individual atoms, earning them the Nobel Prize [cite: 15, 17].

### 3.3. Clinical Milestones
*   **Doxil (1995):** The first FDA-approved nanomedicine. It is a PEGylated liposome encapsulating doxorubicin, designed to reduce cardiotoxicity and improve circulation time via the EPR effect [cite: 18, 19].
*   **Onpattro (2018):** The first FDA-approved small interfering RNA (siRNA) therapeutic, delivered via lipid nanoparticles (LNPs) to treat hereditary transthyretin-mediated amyloidosis [cite: 18, 19].
*   **COVID-19 Vaccines (2020):** The global deployment of mRNA vaccines (Pfizer-BioNTech, Moderna) utilizing LNP delivery systems marked the most significant industrial breakthrough for nanomedicine to date [cite: 20, 21].

---

## 4. Current State-of-the-Art Methods and Techniques

The synthesis of nanomaterials has evolved from rudimentary bulk crushing to precise molecular assembly.

### 4.1. Top-Down vs. Bottom-Up Approaches
*   **Top-Down:** Involves breaking down bulk materials into nanostructures using lithography, milling, or laser ablation. While effective for industrial scaling, it often introduces surface defects [cite: 6, 7].
*   **Bottom-Up:** Involves assembling atoms or molecules into nanostructures (e.g., sol-gel, chemical vapor deposition). This approach offers better control over chemical composition and size [cite: 6, 22].

### 4.2. Microfluidic Synthesis
Microfluidics has emerged as a superior alternative to conventional batch synthesis. By manipulating fluids in channels with dimensions of tens to hundreds of micrometers, microfluidic devices allow for precise control over mixing times, heat transfer, and reagent concentrations [cite: 23, 24].
*   **Advantages:** Microfluidic synthesis produces NPs with narrower size distributions (monodispersity) and higher reproducibility compared to batch reactors. It is particularly effective for synthesizing lipid nanoparticles (LNPs) and polymeric NPs used in drug delivery [cite: 21, 25].
*   **Techniques:** Hydrodynamic flow focusing (HFF) and staggered herringbone micromixers (SHMs) are commonly used to induce rapid nanoprecipitation [cite: 25].

### 4.3. Green Synthesis
To address environmental concerns, "green" nanotechnology utilizes biological organisms (plants, bacteria, fungi) as reducing and capping agents.
*   **Plant-Mediated Synthesis:** Extracts from leaves, roots, or fruits containing phytochemicals (phenols, flavonoids) can reduce metal ions (e.g., Ag+, Au+) into stable nanoparticles. This method is eco-friendly, cost-effective, and eliminates toxic solvents [cite: 26, 27].
*   **Mechanism:** Phytochemicals act as both reducing agents and stabilizers, preventing agglomeration. For example, ZnO NPs synthesized from *Salix alba* extract showed significant nematicidal activity [cite: 26].

---

## 5. Applications and Case Studies

### 5.1. Bioimaging and Biosensing
Nanomaterials have revolutionized diagnostic capabilities by enhancing sensitivity and enabling multiplexed detection.
*   **Bioimaging:** Gold nanoparticles (AuNPs) and Quantum Dots (QDs) are extensively used due to their unique optical properties. AuNPs exhibit Surface Plasmon Resonance (SPR), making them excellent contrast agents for CT imaging and photoacoustic imaging [cite: 28, 29]. Magnetic iron oxide nanoparticles (SPIONs) serve as contrast agents for MRI [cite: 6, 11].
*   **Biosensing:** Nanomaterials increase the surface area for bioreceptor immobilization. AuNPs are used in colorimetric assays where aggregation leads to a visible color change (red to blue) upon target binding [cite: 28, 29]. Silicon nanowires (SiNWs) function as field-effect transistors (FETs) for ultra-sensitive detection of DNA and proteins [cite: 30].
*   **Case Study:** Fluorescent carbon dots are replacing toxic semiconductor QDs for cell imaging due to their biocompatibility and resistance to photobleaching [cite: 6].

### 5.2. Drug Delivery Systems (DDS)
Nanocarriers protect therapeutic payloads from degradation, improve solubility, and enable targeted delivery.
*   **Lipid Nanoparticles (LNPs):** The success of Onpattro and COVID-19 vaccines highlights LNPs as the premier vehicle for nucleic acid delivery (mRNA, siRNA). Ionizable lipids within the LNP allow endosomal escape, a critical step for intracellular delivery [cite: 19, 31].
*   **Polymeric Nanoparticles:** Polymers like PLGA and chitosan are used to encapsulate drugs for sustained release. They are biodegradable and can be surface-modified with ligands for active targeting of cancer cells [cite: 3, 32].
*   **Stimuli-Responsive Systems:** "Smart" nanocarriers release their cargo in response to environmental triggers such as pH (acidic tumor microenvironment), temperature, or enzymes [cite: 32, 33].

### 5.3. Tissue Engineering and Regenerative Medicine
Nanomaterials mimic the hierarchical structure of the natural extracellular matrix (ECM).
*   **Bone Regeneration:** Nanohydroxyapatite (nano-HA) is chemically similar to the mineral component of bone. When integrated into scaffolds (e.g., with collagen or PLGA), nano-HA enhances osteoblast adhesion, proliferation, and differentiation [cite: 8, 34].
*   **Nanofibers:** Electrospun nanofibers provide a high surface-area scaffold that supports cell growth and guides tissue formation. They are used in nerve regeneration, wound dressings, and vascular grafts [cite: 8, 35].
*   **Case Study:** A hybrid composite nanomaterial loaded with therapeutic molecules delivered via a bioactive angiogenic hydrogel demonstrated sustained release and promoted wound healing and neovascularization in rodent models [cite: 32].

### 5.4. Antimicrobial Applications
With the rise of antimicrobial resistance (AMR), nanoparticles offer a novel mechanism of action that bacteria find difficult to bypass.
*   **Mechanisms:** Metal NPs (Ag, ZnO, CuO) act via multiple pathways: (1) generation of Reactive Oxygen Species (ROS) which damage DNA and proteins; (2) release of metal ions that disrupt enzyme function; and (3) direct physical damage to the bacterial cell membrane [cite: 10, 12, 36].
*   **Silver Nanoparticles (AgNPs):** The most widely used nanomaterial in consumer products (textiles, wound dressings) due to broad-spectrum efficacy against Gram-positive and Gram-negative bacteria [cite: 12, 37].
*   **Synergy:** Combining NPs with conventional antibiotics can restore sensitivity in resistant strains, reducing the required dosage and toxicity [cite: 12, 38].

### 5.5. Agro-Food Applications
Nanotechnology addresses food security through improved production and preservation.
*   **Nano-fertilizers and Nano-pesticides:** Encapsulation of agrochemicals improves their solubility and stability, allowing for slow release and reduced runoff. This increases nutrient use efficiency and minimizes environmental pollution [cite: 5, 39].
*   **Smart Packaging:** Nanocomposites (e.g., clay, silver, ZnO) incorporated into packaging films improve barrier properties against oxygen and moisture. "Intelligent" packaging utilizes nanosensors to detect spoilage indicators (e.g., gas emissions, pH changes) and alert consumers via color changes [cite: 40, 41].
*   **Case Study:** Metalchemy and Titan Bioplastics are commercializing nano-enabled bioplastics that extend shelf life and kill bacteria using embedded nanoparticles [cite: 42].

---

## 6. Challenges and Open Problems

Despite the promise, the translation of nanotechnologies faces significant hurdles.

### 6.1. Toxicity and Safety
The same properties that make NPs useful (small size, high reactivity) also pose health risks.
*   **Mechanisms of Toxicity:** NPs can cross biological barriers (blood-brain barrier, placenta) and accumulate in organs like the liver and spleen. They can induce oxidative stress, inflammation, and DNA damage [cite: 43, 44].
*   **Environmental Impact:** The release of non-biodegradable NPs (e.g., silver, metal oxides) into soil and water can disrupt microbial communities essential for nutrient cycling [cite: 45, 46].

### 6.2. Regulatory Landscape
There is a lack of global harmonization in regulation.
*   **The E171 Controversy:** Titanium dioxide (E171) was widely used as a food whitening agent. However, in 2021, the European Food Safety Authority (EFSA) updated its assessment, concluding that E171 is **no longer considered safe** due to genotoxicity concerns regarding the nanoparticle fraction [cite: 47, 48]. Conversely, the US FDA continues to allow its use, highlighting a major regulatory divergence [cite: 49].
*   **Standardization:** There is a critical need for standardized protocols for characterizing nanomaterials and assessing their toxicity to ensure reproducibility and safety [cite: 1, 2].

### 6.3. Industrial Scalability
While microfluidics offers precision, scaling these processes to produce kilograms of nanomaterials remains a challenge compared to batch processing. High costs and batch-to-batch variability hinder commercialization [cite: 1, 23].

---

## 7. Future Research Directions

*   **Theranostics:** The integration of diagnostic and therapeutic functions into a single nanoplatform (e.g., a particle that images a tumor and releases drugs simultaneously) represents the future of personalized medicine [cite: 50].
*   **Green and Sustainable Nanotech:** Research must prioritize biodegradable nanomaterials and green synthesis methods to mitigate environmental accumulation and toxicity [cite: 26, 51].
*   **AI and Machine Learning:** Integrating AI with microfluidics ("Intelligent Microfluidics") can optimize synthesis parameters in real-time, accelerating the discovery of ideal nanoparticle formulations [cite: 7].
*   **Pediatric Nanomedicine:** Developing formulations specifically tailored to pediatric physiology remains a significant gap, as children have different absorption and metabolic profiles than adults [cite: 52].

---

## 8. Conclusion

Nanoparticles and nanostructured materials have transcended their initial novelty to become foundational elements of modern science. From the life-saving capabilities of lipid nanoparticles in vaccine delivery to the shelf-life extension provided by nanocomposite food packaging, the impact is profound. However, the field is at a critical juncture. The divergence in regulatory standards, particularly regarding food additives like TiO2, and the persistent concerns regarding long-term toxicity necessitate a cautious and rigorous approach. Future advancements will depend on a holistic strategy that combines precision synthesis (microfluidics), sustainable chemistry (green synthesis), and robust toxicological assessment to fully realize the potential of nanotechnology while safeguarding human health and the environment.

---

## References

[cite: 1] Baig, N., et al. (2021). Nanomaterials: A review of synthesis methods, properties, recent progress, and challenges. *Materials Advances*. [cite: 1]
[cite: 2] Joudeh, N., & Linke, D. (2022). Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists. *Journal of Nanobiotechnology*. [cite: 2]
[cite: 3] Hulla, J. E., Sahu, S. C., & Hayes, A. W. (2015). Nanotechnology: History and future. *Human & Experimental Toxicology*. [cite: 3]
[cite: 32] Sercombe, L., et al. (2015). Advances and challenges of liposome assisted drug delivery. *Frontiers in Pharmacology*. [cite: 32]
[cite: 9] Mitchell, M. J., et al. (2021). Engineering precision nanoparticles for drug delivery. *Nature Reviews Drug Discovery*. [cite: 9]
[cite: 53] Patra, J. K., et al. (2018). Nano-based drug delivery systems: recent developments and future prospects. *Journal of Nanobiotechnology*. [cite: 53]
[cite: 35] Raizaday, A., et al. (2025). Nanofibers and nanocomposites for tissue engineering and drug delivery. *PMC*. [cite: 35]
[cite: 5] Khazna, K. U. (2024). Application of nanotechnology in the agricultural and food processing. *Khazna Publications*. [cite: 5]
[cite: 54] Peters, R. J., et al. (2016). Nanotechnology in the agro-food sector. *Trends in Food Science & Technology*. [cite: 54]
[cite: 55] Parisi, C., et al. (2015). Agricultural nanotechnologies: what are the current possibilities? *Nano Today*. [cite: 55]
[cite: 39] Dasgupta, N., et al. (2015). Nano-agriculture: A review. *Environmental Chemistry Letters*. [cite: 39]
[cite: 10] Huh, A. J., & Kwon, Y. J. (2011). "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. *Journal of Controlled Release*. [cite: 10]
[cite: 37] Sirelkhatim, A., et al. (2015). Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism. *Nano-Micro Letters*. [cite: 37]
[cite: 56] Wang, L., et al. (2017). The antimicrobial activity of nanoparticles: present situation and prospects for the future. *International Journal of Nanomedicine*. [cite: 56]
[cite: 11] Dadfar, S. M., et al. (2019). Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications. *Advanced Drug Delivery Reviews*. [cite: 11]
[cite: 51] Apple Academic Press. (2024). Sustainable Nanomaterials for Biomedical Engineering. [cite: 51]
[cite: 45] Iavicoli, I., et al. (2017). Toxicology of nanomaterials for occupational risk assessment. *PMC*. [cite: 45]
[cite: 6] Hembram, K. C., et al. (2022). Nanomaterials for bioimaging and biosensing applications. *Nanomaterials*. [cite: 6]
[cite: 28] Lee, J. H., et al. (2024). Gold nanoparticles in bioimaging and biosensing. *MDPI*. [cite: 28]
[cite: 57] MDPI Sensors. (2024). Advances of Nanotechnologies in Biosensing and Bioimaging. [cite: 57]
[cite: 4] Chellappa, M., et al. (2022). Review on Nanoparticles and Nanostructured Materials. *ResearchGate*. [cite: 4]
[cite: 29] Zhu, D., et al. (2023). Biomimetic gold nanomaterials for biosensing, bioimaging and biotherapy. *RSC Advances*. [cite: 29]
[cite: 13] EUON. (n.d.). History of nanomaterials and nanotechnology. *European Union Observatory for Nanomaterials*. [cite: 13]
[cite: 17] Fiveable. (n.d.). Historical development milestones nanotechnology. [cite: 17]
[cite: 58] Barhoum, A. (2016). History and development of nanoparticles. *ResearchGate*. [cite: 58]
[cite: 15] Wikipedia. (2024). History of nanotechnology. [cite: 15]
[cite: 16] Ossila. (n.d.). History of Nanotechnology. [cite: 16]
[cite: 26] MDPI. (2024). Recent advances in green synthesis of nanoparticles. *Sustainability*. [cite: 26]
[cite: 27] PMC. (2024). Green synthesis of silver and gold nanoparticles. [cite: 27]
[cite: 18] Anselmo, A. C., & Mitragotri, S. (2019). Nanoparticles in the clinic: An update. *Bioengineering & Translational Medicine*. [cite: 18]
[cite: 20] PMC. (2023). Nanomedicine clinical trials recent examples. [cite: 20]
[cite: 23] Thomée, E. (n.d.). Microfluidic nanoparticle synthesis short review. *Elveflow*. [cite: 23]
[cite: 25] PMC. (2022). Microfluidic synthesis of nanoparticles for biomedical applications. [cite: 25]
[cite: 21] RSC. (2023). Microfluidic synthesis of nanomaterials. *Nanoscale Horizons*. [cite: 21]
[cite: 40] Adeyemi, & Fawole. (2023). Metal-Based Nanoparticles in Food Packaging. *ResearchGate*. [cite: 40]
[cite: 59] Sphinx. (2019). Nano Materials in Food Packaging. [cite: 59]
[cite: 42] StartUs Insights. (n.d.). Nanotechnology Startups Impacting Packaging. [cite: 42]
[cite: 41] MDPI. (2024). Smart and sustainable food packaging. *Foods*. [cite: 41]
[cite: 60] Food Compliance International. (2023). FDA EFSA regulatory concerns. [cite: 60]
[cite: 49] FDA. (2023). FDA response to EFSA on TiO2. [cite: 49]
[cite: 24] Niculescu, A. G., et al. (2021). Nanomaterials Synthesis through Microfluidic Methods. *Nanomaterials*. [cite: 24]
[cite: 23] Elveflow. (n.d.). Microfluidic vs conventional synthesis. [cite: 23]
[cite: 22] MDPI. (2023). Microfluidic synthesis of ZnO. [cite: 22]
[cite: 7] RSC. (2025). Microfluidic synthesis of nanoparticles. *Lab on a Chip*. [cite: 7]
[cite: 47] EFSA. (2021). Safety assessment of titanium dioxide (E171) as a food additive. *EFSA Journal*. [cite: 47]
[cite: 48] EFSA. (2021). Titanium dioxide: E171 no longer considered safe. [cite: 48]
[cite: 61] ResearchGate. (2024). Nanotechnology on the food industry applications and challenges. [cite: 61]
[cite: 62] PMC. (2024). Nanomaterials in food packaging and agriculture. [cite: 62]
[cite: 14] ResearchGate. (2016). The Lycurgus Cup - A Roman Nanotechnology. [cite: 14]
[cite: 63] Early Church History. (n.d.). The Lycurgus Cup. [cite: 63]
[cite: 19] ResearchGate. (2021). Lipid-Based Nanoparticles in the Clinic. [cite: 19]
[cite: 64] PMC. (2021). Lipid-Based Nanoparticles for Drug Delivery. [cite: 64]
[cite: 31] PMC. (2022). FDA approved nanomedicines. [cite: 31]
[cite: 50] Diversa Technologies. (2024). Nanomedicine in 2024: Key advances. [cite: 50]
[cite: 52] PubMed. (2024). Pediatric nanomedicine challenges. [cite: 52]
[cite: 30] RSC. (2024). Nanoparticles for bioimaging and biosensing. [cite: 30]
[cite: 33] PMC. (2022). Biologically responsive nanomaterials for biosensing. [cite: 33]
[cite: 8] MDPI. (2024). Nanoparticles in Bone Regeneration. *Journal of Functional Biomaterials*. [cite: 8]
[cite: 34] ResearchGate. (2024). Nanoparticles in Bone Regeneration Review. [cite: 34]
[cite: 65] PubMed. (2024). Nanoparticles in tissue engineering scaffolds. [cite: 65]
[cite: 36] PMC. (2024). Nanoparticles antimicrobial resistance mechanisms. [cite: 36]
[cite: 38] RSC. (2024). Nanoparticles antimicrobial resistance. [cite: 38]
[cite: 12] MDPI. (2024). Nanomaterials to combat antibiotic resistance. [cite: 12]
[cite: 43] PubMed. (2024). Nanoparticles toxicity human health. [cite: 43]
[cite: 44] PMC. (2024). Nanoparticles toxicity human health review. [cite: 44]
[cite: 46] MDPI. (2024). Environmental impact of nanomaterials in agriculture. [cite: 46]

**Sources:**
1. [mdpi.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHit0wqIHmMMKWjQQ2LsJihFeK-0EG-alwKBOR8c9iH8sxftVgAZmwACYdLheyEIsU4UrJv8X03wn_X7ol2An4Bl3-1sESSLAHsO1Dl-xwxEvpEmiym8xLHgqkrJT8=)
2. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHKLYSC_zfS6Iqo-YBvNqi0hOxt9UCblMzmNK9XaiM5CoUVsGt5-iXvL9mZygeqUGEfMvewrqzmlgOwknzvFaB6oCtqn-e70EbTu6tZrMobTQqxKI2mC1Yn26wGMprgnQ==)
3. [mdpi.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG0dtAR4CLtONmpmQUURX1h1fDrOhaHWfVdKPZ2WWKvk3H0Pt3zOnhEc-JhLMC-hsfnsghDJOYvoaccZIb8eW_yAKS6Ti2CqALNCyUQgFbT64Foh_nUzp-zsLNlN71C)
4. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGcxs5pBx84MJW4LbXRAZDGp0ID00XjoegiK1ZSmGQHDtt5-AQnygijJsLA9kaWscDYE9vyTAcg_YFkaYwkbbYkzWGMeOfdv3hS9AnJTLF6dxaTf99WV2Mw4MiM3nc99dOf8q91JDWJWpzBoh96WIpXykOVGFP_yHh5ubZMLt8Vh1Z3Egl94U0yP_htl40tw5fDJyXvdtKjNUnt-SUnIECNdb86II2PsiGPmE7uBDuSBfyhd0uQ2zTX-Rj-z1-9etkfcwWzJ6cWRsGT39qwASOryerRoARfcgFWEUlQ3enmb2HZSrFi9VmEZY-Y4TWDv8Br)
5. [ku.ac.ae](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG5w_VSV5NXao_tFiXTNptfK6yE28YPKogJ2laxf6tIGCh77b7mdSOlo0HJPKep40xpc5kpIsN-mmOrfTK84XL2PKW6Ha_GlarOdAjWtoqx64rj2O08dx3KPfwyOsakEUitbEU9tXOi5OWApn0DF4irAU-HBIOBqE8LYRiRgfBVT6Cl1vSixyOR4yrsFOvqlVVX6B-5qG8eT2dspoZlj29O)
6. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFrOwX9B2xBZbk4-ETu3Q8qtNdbBdPhsa4ke5iFsSHaVotoyLNHelNf1dgJszagz1QRQyuijkXE2BRse7yTJdW84u2ynfyJ8MSiR1DgapmJHKQma6bzL5O7XuOMhBtoliTsn4xHhtsb)
7. [rsc.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGwKF5gdGDgDTS05f-fwy4BWbGuJq02k7cYQK3TVpvjX-aAX_2JqegQv-RiVHxO3wR5YU7NvNna8lQxQN3iQht_I8Z6KD3h_hlZoehRchO9855m8HN24bKkonhgv8U7Gln3_5V5Pl126q88ceqDopluBxeUiQ==)
8. [mdpi.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFtp6x2NrG_i0GG-Nbs8a_P_A2hfLm8K1njmH6q93WSYKKMbL9l-P3H1OGyMuaoKGdNC_HQv9gz701FbmpYEipeiXZYt6yBrIN0NcefMemXj09LzdkSZy7kEd1hWxY=)
9. [tandfonline.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEN8RP7QeTKBS4oXKFX_1HI1nAqt3p9OaL0cRP7dRavLKsOs2ONuhFC8qFHe85ziZM50XUz0wk8PcDXOCzURJnjsMrk1hyxWW_QvPVNu0uT8LDfzduWtUyJ8P-0Y_kX0YeAJkMxwFteRYzWfMnIhRD2dGJP3Q==)
10. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFQ2qqdD98psn8X5-iO7weyDeqPv3fwJfV9k-X-Qzlx3cZMZbrPWnTGIjtSz7OedPN1Jd0fs08jdw13z5mqJH4-dyRnLcPLAhUGwui6tpFjYAgx3u-HUY5BrgM_ARExDTDL0vmGt0qG)
11. [rsc.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHvQ4oI_NJ80qhpG0F7s0u5NWsrDCRtGniY8d2RwagBkVlxQnnBXFt4ePF0JEusumLJI2Ejxft2MDHIGsgGDIptvssRI_F7qF4lWvs5wVBwNc_mRfBdPKTCpPQvjDCxekbGcEP06QCDylL56mm06nmBCIr_Xw==)
12. [mdpi.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH6FpnUZn4GkrG-Eho-v_d8nYixq-kH5l8H1d7cjG8aZsEcqnJCEuuJ690ZljTaq-Om0I4T1YwtvIvi6nXMZOuF9ks3qSlA2UDBrhd8jUBiBlY0nMSdcaTbhrfP6V4=)
13. [europa.eu](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE7gVrfuSerDpnpy2k8XCTW5AYyq2PBvh7biEpzHNaitUBiu1suN_uC1nXnthMMdj8uHmM4T6hzwm5DClPjaRxwVPStQjkLe5ysX425tgr5tQOjexIaf0vhmUZSZOeo-ckxkSpN-UoAlVBaH3WQxVuTGH38XTf2A8bTgt-9-g==)
14. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHPpzCBvQmdyPxUr0Ny26F6CYXEu3nfaCuYcMmcMZRkL-BS6sieyB-hUBRctEqCii7bxSUf2WGt2ZOd2HV9IMnY4Z5Z-Nj4x8aorWRuy0Y_Rz2YZ04h0peJEINXoHKaI9qWd2tdEGbVgHVqoGFj_o3W1_YcP0FB4pl5ttXSr48o8B-AwjYQQjL0_GKVO9Ato7-LB_OcduBOKSJgB3FRxWBciaE2dve36UWidygJBGmUJGD2f4ZO)
15. [wikipedia.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGd97nC9iyIyAfHamOXZaG_1mYQOxURmXjuFSqfZvKvBGKrBFUttkddLDpEZKc_NmTSZe4dGhJp9TNkB0ampPlfPnaZwfnIL_6sOUszbUekAABIAv4pu7C55uN2Nw05yAyh9tBSNLKX0mucg7z4)
16. [ossila.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE1GZoTHOkUob8CzS6CeCcOiy0ueCsedURsl8eNFJPDT19RqJWFnvburbvixr65h64jDO-WVPJLQDsVh6NYO66QkSNAWgeWFklpMTgp1dWOhaLv3GmZ8gt8LDDALrZVjrkho2IqDr66F_JPES0=)
17. [fiveable.me](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGNtpNtf6ire1CHj3dSMQPSJwG77Z-fdS0PaKAeo3UAcEBEYKL9jqE8y-RAnc6mrPqkdnlbJHd5JShu-8GneV4o65-LjuSGPuBm93wlNk7K2Nr217dvmuaBX6yE4x8dXdwB5fv51roi7JLnsl_3aEAs0USL7g_IfAMbPd4I8X-iKyTCA2cjcgl-tADj7mi4uGtZf9ud9ZbLnLF7u9ACBiMNqsgXeJgpzUWBVhLzIW9lmEew-fqrki35hhSc)
18. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQElLfU4Ro-LcqvCmDUIdWUB7JnS2R7qCMIxn9h55O1N8_NRYRZVG5vk7VZ9nQ_tEvvBhtxeXMYbTWNN-OnZexjrbkQvs_aVyhhBjM4PZhSpoEVCTv89ANN0kfLa_w1q-7XV63PoSGjP)
19. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFzb3RUJHB0BpOjfXqKcrv1L8RKKr8BiXjVDxVgnlzUEzEaQLuPIvWNU5acWOUz3bhih4PfVLedfpg7AfIO2Tkd0nFkBpSn99xxb3lnHKD50WMFrgT7bk1K7aTsbheoQhCR8aOiyaTc0aTbFYSgXF_hrTrbeuki_545OpdELGBuhPfg7BYoQt5nWmOUPehVgtgK1AfZYzeB1bsGkEhJe7saQcAoMg5Hbssen0MjuWIS89jzpNM7jm-U0qLEQz-F)
20. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEO5p-mDK9a6PyWcSGnGTvPSI6v8CL9mhn8wMbk47huTCFRM-MSxsCvTVDSgbbjn1cWBrRV2hMEvkvBzdbARhUU-Uh54Yxkt8Q9LsHCzbMQhhT-SvMhDCToNqDj1HMtu-PbO5FvP0r0)
21. [rsc.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGKYKnE5MrpWavDRkucPtlWzABqKOEc7ztEABU2HwCBdJqHNomaLlEtfFyyyvs3EeaUeB-jvyCqGXG_KUy5D7GJsTadE0vsNGGm4fQQn9H1JhGnSQrbHU_e1J5T3WhEJFtVcvae63cgfREm5e87d-PbiK2M2VwFXQ==)
22. [mdpi.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEbIuPieS9ObiPZvBfcY4GhjgYHs3otRY9r5dLuSB_0yhOQnO0AaFunaBXY76th4KeyiZ75uf4t03d-w_GPWyQxK4798L4BTrfNHBxwFZ9TCxoIUjxAQgC3zu970j9-)
23. [elveflow.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHID9fLVPbfC4YdwMpGgzM9727uZRgcowUewXDxgcL47AcUWYRIWBQ_YRMMgM6C4_S9TClXynb3X5xYylULXjK4W_9AOz7N7K8iZE_KMnBPPN0xVCJPCBmV8r69reCfWDS1oI2-LiB__wz4r_7ZcIWeaCBxP5KW8_stP6L8iaKt1wDAtJgWd0SIek79GqtIsMDP)
24. [proquest.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHA7IEX8VnnVArBU3OBRsG0CvnfjOm0-l5DN9PV9Sa5kdITEOS5h928sLHEUvWK-2G5aBIpqQtjFTW1HKsz072MaclXtZT4wwrQqsyYwSVqCkJhXKkQmMmYNPFs6RBxH_2-56kf2INuFlHP6FZRYqqqkPYEn3LhehJgr_3NRRLPSkkzQ3h5n7wd5LMFtvmq0-sdYgafuZdjhAVvy_s6uQ==)
25. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE9esCqzyl3eSth9mpwAnEQ23Nh2SmPCAYbfVDlIhqmwqH6rths518OUW3okTBKJH90TxdRDh8jd85xrHC6WEWd5xAjLuZeWimWY60zerlppVPB6HRJuNvrUJmgFivHgSoBSswve-Rh)
26. [mdpi.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHwsdWNMV2PPp3BYiXcGlPv2QhCBmU_Nif8l0hLi4tk8DiGbOgxgj7sX8znlvlFxHpG3vBTvk2m15Z8PmQ8nieoj-dh7Xho81IwPK7gO1I9v4pmZl8gjPaFHzAKaFbK)
27. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFO_cYosEafFFMBdZ-2G9dC8wMJQ7i-EJUvn-iegNJBKR3BhO01GJ4_4OgFfmG8WfI_ZvDam4SIRQUJB6qK1eEHFVL2maJZuyWJQhha2Aojp4VNxXaUMJiM603qok_R_-9ed41U4hOxfw==)
28. [mdpi.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHCYDN2BlnEotVTEM-WoVFQtpnshTyECUbhRVbqjHfxboYehXjPRZaoSGQPPfzvhD6IfWb2rtRK7RiXwrTrxIyw-wW7unm59HeGiV-Kxcms6XDL5dVD8PbTGqUmtw==)
29. [rsc.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGVoiB_nxrtPTkRHCfReqSyJzXchzdljP-x_SyEn0n_2mYG8G_Xa8Fv8t6gC9MaCoeeinuECTJK4EfUN429-hVv36d3ppJEEkMIGkv2eLHuyZSsTUrU0PU9aLyuq_jJJKjEz57reCmdkRltbK8CRSWmjsm3Ww==)
30. [rsc.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE9-cIMLjmfY5_2l63OOF1jHRkQoH6Pz80BUq4zjZLOht82QLneK_Yg6c2Ya8iWcyexovQdYlfGH6HR0H0TvlchdrQDd5nANJqJftXc3fmn2HbkZu7qLqaFkat0cZNuivWxPtCp_gOS4gj-vM80DxD_zaHS4g==)
31. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEUu-K2RrRrmC4fcjMcHXsByCEUXcfqSuFYwNf6b8ed83WXF_7x9OUTtExG42rPvONTA1FNqxO7xLrYKr2seQ_8fcxhCy2pkslOTAJjpV9PPQVHyLdzlH15CPMsqQPdt2fS2wDmVblpMQ==)
32. [tdl.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHTtvrJGcQVZi-cVnspE4QH1vRz-y0dxQIldSpWbDTSRLzIQwRxqlNzD01ciTCsiAFci2RXCIfN4niZ1OFsrnpyERlRY3gPapeoeis7NKpjwzMD5Iiue6m18BS9swawolhZijhrnGOfJmK8XbyGjwGeht7EFSKx)
33. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHPYmNPjcHwhjbt86e0j93i6EhKduzsvEz9Bs4-XHoz2rQY0pgLeSEtZKGFuzY96I_LtWgbF0w8bZMutg3EdlcdqajPtY7MFZthN9yjiKR7gm7ii3xUQAm2jbsin4hwrcnPxrJgxMoq)
34. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFsx083cQFbvZ1lGDJmmLpRWDg8LK5XnA95rrTEJ_rZdo2IzPDaGONqAfsFLA1TvzYt1Jx0ghFTF5w62cFAtEWHV8b-F1bTlYsYR36j4E6eShRFZ75t40PCnyhlslV3RPjJng9COntPPZMFnTyRnUvPPqDZWH8vVic9EhkZncjdyjd7ZgLc0_RdP6TxcTSKS0dfk5nHCso7tq8ZMw-_OFKya7_Q81YicpE5srMv1TrBU0qLnMA3_wdHusn07osh1dphVx3pivwW7hrHui7Yu-n8NUM4I7wD0ZrS7e1GTLez)
35. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGS9h334x1mxvl3kwVzr9ZczxYVi5zYmK7SdvEv9ryrIU0L6lXx_QAL84SPRMxTGqS1u0aA9cI6krEIVi69hO2VBrl2YQvl0NSwsnaB0LpjfSpV8J4XD0-g2FaJmvRIX17jRXTO1KnN5g==)
36. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF5wv4kLOi3yUY4dRxxsiwDKGEcA1ta_FBTEKCN_9iwCJmddTsyJBB6FuZ90xdBZH8IDXIJnn4kJbl3UqeuzhMWKMPkGJCKNLgl1eI7rK5MODFGaayuYAFqqV5raDFNq0I9SNpk0dkNtw==)
37. [mdpi.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEKUj9tLa6-GO2oSxQzzfrOi_8sg3BPFlk4Ba_TVNYCzi0jz8mDptYaETXrXoTZRGC6JwMKYNqbqumG9L6ZvcSO67ZHiq4J7cN3iZa5h8bZZ8azqPoZMwncS26z)
38. [rsc.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGzHIej4w5r58uk08Vw6PamaJq0gi94_dPQNsR8WnOFMk-pOD94A5DNtfeBSRG3yvUNxG7LiqTs6Um17BYlNtrmtxJfg9LHUbbuTO9_llhJwX9OvBeaKjaSdqz2P9CX46M0UsbA5nrvqNAFz6j9vDUJz1hxZQ==)
39. [scispace.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHFxHnnuarFCmASmSYp7FQQNicrBcpLoEBNPQyk97Un0uEKKwlF24PVaqJ8TWjP-J5TS2ESlta3IxL9tewwTjKBgWo1BVh0Cj0Rnnmjuj4OiT2g-RfdtS-cbrCfasPc0P8Gk8V_VVOsu91YdxHZAPtoJu2rGKeHUs8iL_-6RT39RQiUWRSBWLaTrqOv2AeWmuKvX8E=)
40. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHyS_yawiormNUQaxJZFb8VMmPc15BXgbm9RaGl3j1HKp4tR02Jn1wKiebsvmX_YTXBQQ3ftk71XA27nPk8_BT1vYVppTTBmcch8_l2zKfZBQFut6zKxyFdV07yNfQREjRthSttb1URWgpTj-2VSOs0tAbB3fnNhis8P_6wyRzFpvsJEZHkh7L_dbKNK6J29eeGaN0ZzxmE9yu89moUHppE36KXfAFev7g8Jt8FhLvnX7dYOrFypZyVL20EcAW1XQ==)
41. [mdpi.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFP2yaOJ4v5EtpoFpxlEu807OSUsEAcKIm_hPLH8OEmZnq4ems-6E3MoLFb1Gof-0KQQiQB-AGmB1yT6mTJUmcy44F7W6LYIbe_hRJRRKTT2y-Joj412JPxI9bqVEHSGw==)
42. [startus-insights.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFo19deQAD1eUqZBQhFscN4Qp_RGk_r62tVrtLsxmzmmItVBTq-MzeyPdEwdkJbHDqiNftFb56lqeG1JrrAEehIaiv7y3jkVGOAWbb1xFhumUNxZ1uOiwccuL9_GgUyLsA22XYjCoVljr6sBI8f6y8XGCXS0hNf6j4uaKDZ3y_zriw-9yglYMFXXdIQJ_klICjryLbX)
43. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEHdcZwy5RmjQMbkWCKYYhdoox6FYQbSvcuNUZwDYQHsJxlqqdHLNIWnMicdNr5kAek8tCmndvvdKMnKagmVRr2I4Ll4kaO6lR6vbG6LNBEJ1ari28wwM0kj5Py9Rk34Q==)
44. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGvOriBxmFADCmtynKBeQ12PwfIlJZtKptSBsQmAbf_6Id8SQzBWajZeMv_YshtLpGu2F51-XE78U5IRHwJB5Xh9VFmQIqWgOqusLMKjjeZIBfSBWI9Ap0a1WagxVKGxa7GNbSSXjZeBg==)
45. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFllQLmGeZiWd0_dQy_du-FQI5ntPtnosRDDDoVgrJqymjux7yX3Ol7rOVllhSNfGq3q4Z-TIvpbA39Rm_qSNlvQNJGghYVEu7nOxj4yUpUCVXMIUQYolP815sDS6g-dCGXLeshFneQ)
46. [mdpi.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFyXgsEAU7s4pguw9YdlO5ML5m98p6NlkCGvy1xdRCwthnvZbS4SMoorUmtjhtunOsGNvfl0aNPYQ5Ag7pIOE_Cvr6TcpBcCGG80aeY4NeFw65twIU4BFxaitVPEBSeDQ==)
47. [europa.eu](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEzstLFSrp8sySVTGsovblA9wcwLkgMrlqFAwuHvC3XkU-vg8ADRAVCeO8duYF4BVPT71j0XcYg-fTmNhvZn5Pnpze72RafJA3kfLwMoI8Cilr4KbD6SaPrdF6rYRlqTNDjmJsSdYv-Zg==)
48. [europa.eu](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFur-ClGNkmqkpvXJi7jXmU7uii_Ofl1O_XkEeO9YRQFkzyPtC15uMw24Wa8hFBwJuJTysL80Q3nI7VfGvcAaWzyB57iYUTBlF8ggaF9hPUeCvB3jb9jK77UCq_Orc3z7BFdqpl0s0FtEcdTFRAk8gVhTKtge0kW2PCJXWFjwB2DeaHMp6P-uiIVjgjxDZqbG1SmE9lwW77eAanXsHjRY3n)
49. [regulations.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHcWAGRAeiQ2kIChMFfblP3KQfaWe1trQG7pOaFF-0KyWrR_Rv6QPaeAjXXO5kGz3Ehplz4PLzSNFrgxXiFMBZeFv0NunLVeqsB9em57L4zcZU_b5L_7C-SuErDotU0ZuVQdjQyCyrE9AcrmwyEepHUqF35fEQLbUOIDoAcXg==)
50. [diversatechnologies.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQErUv5Uz12EcVT2eqMHBClo9g-9i1MV5mmv5r9BslMAvphLW7ly0QgsAnSO5xkWjH0U18iYksBn8ZkryYDVmUmHKl0T-jWaqTolk9HUzU1CtE1F1oJvTdk8Df_AvuCW5gy9vTyL0QC2ptNbsl5-fWRN_PP9_KZ9aGZfXxEc-zyTpArYKYIPA-6Bh89un9GXZX1uzQ==)
51. [appleacademicpress.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFCnMs5pEp_XTL8ZIu6Ckj39RSWut8EMMtJLeASHZM9ahwCc2BKYspIrb4-9QTgCLVn3iNfCukqFSb70wSv3Ua1sELpyW6LyCvoK5-0OuGcjD_xauCN8HxVSECERDD1YpFDH-wvvmm6RioSTOd51TPVR8T9_GiK6CHtrv3feUQChcPzSKjwlRIdulPva144GbTA06EH9Gjf4L3j5Wkfiz4fnSW87lT2zEAHqyBYUMd2yUyWuezKHmPcrJWjpphWWz8j534n)
52. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGB9_tvyPp8gCFMRZHwQ3GW9mnZ_ncOVBDAXApH0QLN0mR2CCSCd_wobph5Ayytw99kUl2Ty9YAJzRxheTfgkqEG8rljrg65GFuBt97CLOVa6RMNw1-xjOtWnBCHT52Jg==)
53. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGAp6e2Gzjhavg_eTlL-Zl4cZbvuXTE2OHt0zDrwsDTgcA4f31Fx07_ybZxBpBOL5DZClE2FVmjoevhI5d1yys_icum79p9QWIa42dJYVPBH2YGNbo1MINFhlmk-35EI1rDVXJjMIeP)
54. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGb2oSdDQLMx2SwI0cbemxLZQS8Pa57GvQwAV4-ZcMLQQYsQq7chcmQpvUeLdPxIiwClH7MDb9JhOVllG2gl1rudwoUzLb5kRrMyuPqyfgoPv_lPB8ouDRt8Gq4MF6jecKGtlmRUseXyRQK_s137rk17TwHhYnakRLfE_Ds9i2BkoJyGrws4HCD33CcywL1UWVSs2y205WRzbbYYA5tP5MGOCIU9RGHvHUh)
55. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF4RGcONcvdK9zh5ikFwblLhFpOTccAySkrU4qgCew-6Bu19qsvvPSCNl0lWX7dc9UdcjRXqMrRZlUtF2R1T3-OQWiO7CRT9Hgto30hGFgA8yM8dL6TwcM1dhQlXc1fv8kPW1y2x6r_)
56. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGCK25Em8UFYToEHrpa0WrEi-midXpR4XyrcdOTs-OT4CIYkcM254dTSkqHi_GSdLNYkN_T1JL__PTVnlTvk4xAI3L-Mlj_ZC0JAW6mjSEPvFv7Cji5EVufJadIx80X55pFBsWAzMZa)
57. [mdpi.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFxR0BT2sQpMysR0mnVSZUEc2QCMS-4WcHbyEg53i04XkZWnDN47KMfgJV-HSZ6bh2vj_Zqdp0RifseSsXFI6lu2QcP-7JupoLOjdP5lB1jKx6yYWAldaky1KVe64uHnT6hQ4OnQzT--yVCqtiJeht9-ic8n1jv)
58. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGiorWUZJTkWGlktlHzFkIlNtjZZMKl1X5X5I0JyPntE9c11jO2G7mrC9Gd-y6XqTOI_I7T4mCymsDu0sGUbJF19t-lPRnoel1jOZbnT1M6QNAnEBWFcw-_xTQmUvg2edbp_I2-DCKaVYTsVCTYCYKlyiG9TzGeVsT-Af6DKFgKKPH4g2WbeGisxJlIyoyHBB4BDprg7NnKjGirb4mMK0kJPSUAD6Pgrwdxw14DZXA=)
59. [sphinxsai.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQECfHujQj99p_O8sO3rsZH048-5EZG6em__YUeDV1tmqF-GW9m-E3924i-7ksTcaa1RfrkDbV7oWNtpyq2k1IELCPJ7tnf1f2bLhuO_iOtCmldcJ_lRL999MVlE06RVqmnZN2NEFKB8OGv28RL9sNgKVl8=)
60. [foodcomplianceinternational.com](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEBQiLj9_Pm6xmL0Yo5cl2zxuPx-WmIRvRCykxgiB3iCAAGT4-NC4O0X4IKxIGhcLro5x2Wj8PolNLkH9XHLwQ0260hmI2xtL_Tl_dh-ybhfNrU-av8wBjrjkPicMW6IVaT4EtizP1zQ_sbFbpZb7FwT99urfJRe1Soo9jn4L0_KTBDL29cYHGIL8j6uM9auCEInHXB-qr5HHOB7MqKZCyMoq_qpkqkGLE9fhyzlNlnbq8oDLDDyOm2cfaHPUGBH5dXDxYycJrqQb9v21jry_kybIjirr0vdRm_5QyTXLslySW-9WA4-XcV2EE=)
61. [researchgate.net](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFhMq4ypKA_nKtXH_cyP8xL-0hNFmJSaG_3R4zy05eInRyhveMWNN9sJBHFnpvza9Y0Qu-HmY_NzDkRq3KWlLaJB0lL4_5GnuP-YlFp1UhwwDjZLhflLnbg28K5uXv6YC4r7jX1B3MAPy26NRHvZAEdZdlZDJUArD5JX-v7Os4vnvboJSw90Rz2oJyILVBQkiFJGKq2o76F2B63tcKpHcj6U4AkOYJZNb4=)
62. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE62uqlZyHWn6IHKzJrI7fArNcBNoBtGQe8trAL7yOxB9iGvb3aRGJOpyGNWoGGmnEuoEyg2EZb3nUoU_uOmZOUFQK0hDH3OtHx1tAylhi81eiOyXYWJlRFZlisDLO4S510-D3AGspeCg==)
63. [earlychurchhistory.org](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHWHRKx7Un84zXUxCWqVQnVRzso8Z4bJD-HV0CuhyaY5SXyX23yFDoYjeqnoP9POI6pKDPNPpNXPlPh1HR8qIvPQWFT_xt2cA3gK-unR8iH8Bqn_fpKz-BV6crfRZ9e2b0S48MyTzchCuM3vPcN9syPLdaY66mFd1yuGb24gXSa0l-IX3aqPiFADAJkOEfy)
64. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH4Mos2jKI-d-WwK9eqf1-MQIS2UIo5iU3usMzKN-TnH554MsRXT4fRAkn4uD8tFZi3P8RH82hzeDkHAtavV-dfNljGFuwsl4Yk0vvqrnlZPNct3b0fwA5YMZrWL3DaSSRIpCljb-Hc)
65. [nih.gov](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGSmIkRfCD3o_CNWWs2KOd4UK6eZm-y2VXaC8-YP2p98AiFx18QQMfRX_6-Ig_rMUeh3fB4jO4JRc5GA9oGijhSl3-PHihSZ6istmhs4lEDhiBflOY93Y1yUDcxmaCgrA==)
